BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32014143)

  • 21. The management of primary mediastinal B-cell lymphoma with sclerosis.
    Brugger W; Engelhardt R; Mertelsmann R; Kanz L
    Ann Oncol; 1994 Dec; 5(10):943-7. PubMed ID: 7535081
    [No Abstract]   [Full Text] [Related]  

  • 22. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
    Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
    J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
    Hiniker SM; Pollom EL; Khodadoust MS; Kozak MM; Xu G; Quon A; Advani RH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):99-106. PubMed ID: 25863757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
    Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
    Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of rituximab-CHOP therapy on clinical course and autoimmune parameters in rheumatoid arthritis associated with diffuse large B cell non-Hodgkin lymphoma.
    Vujasinovic-Stupar N; Pejnovic N; Markovic O; Babic G
    Ann Hematol; 2008 Sep; 87(9):767-9. PubMed ID: 18386008
    [No Abstract]   [Full Text] [Related]  

  • 27. A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation.
    Liu X; Deng T; Guo X; Guo Y; Wang L; Zhang J; Xia Z; Zhang Q; Xue K; Cao J; Shi J; Hong X
    Hematology; 2017 Jun; 22(5):258-264. PubMed ID: 27884092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantation registry.
    Kondo E; Shimizu-Koresawa R; Chihara D; Mizuta S; Izutsu K; Ikegame K; Uchida N; Fukuda T; Ichinohe T; Atsuta Y; Suzuki R;
    Br J Haematol; 2019 Sep; 186(6):e219-e223. PubMed ID: 31355916
    [No Abstract]   [Full Text] [Related]  

  • 29. The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP.
    Dawson MA; Mariani J; Taylor A; Koulouris G; Avery S
    Ann Oncol; 2006 Jan; 17(1):176-7. PubMed ID: 16157624
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapid and sustained response to Chimeric Antigen Receptor T cell therapy in double hit diffuse large B cell lymphoma.
    Deol A; Uberti J
    Am J Hematol; 2020 Mar; 95(3):333-334. PubMed ID: 31429117
    [No Abstract]   [Full Text] [Related]  

  • 31. Chimeric antigen receptor T-cell therapy's role in antiphospholipid syndrome: a case report.
    Schmelz JL; Navsaria L; Goswamy R; Chuang HH; Miranda RN; Lee HJ
    Br J Haematol; 2020 Feb; 188(3):e5-e8. PubMed ID: 31721157
    [No Abstract]   [Full Text] [Related]  

  • 32. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
    Weijs LE; Arsos G; Baarslag HJ; Wittebol S; de Klerk JM
    Eur Heart J; 2007 Nov; 28(22):2698. PubMed ID: 17567624
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiac involvement of malignant lymphoma presenting intra-ventricular-wall nodules.
    Shikuma A; Sawada T; Uchiyama H; Shiraishi J; Oshiro M; Kawaji Y; Koshi N
    J Echocardiogr; 2019 Dec; 17(4):222-223. PubMed ID: 30506180
    [No Abstract]   [Full Text] [Related]  

  • 34. Epitrochlear lymphadenopathy.
    Pannu AK; Prakash G; Jandial A; Kopp CR; Kumari S
    Korean J Intern Med; 2019 Nov; 34(6):1396. PubMed ID: 30514055
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary diffuse large B-cell lymphoma of the testis relapsing in the right atrium.
    Yamamoto E; Tomita N; Ishigatsubo Y
    Br J Haematol; 2015 Feb; 168(4):469. PubMed ID: 25403768
    [No Abstract]   [Full Text] [Related]  

  • 36. Heart and lymphoma: An unusual case of secondary cardiac lymphoma manifested through presyncope and syncope episodes and atrial flutter.
    Kaiafa G; Bobos M; Savopoulos C; Koutsokostas T; Kouskouras K; Kalogera-Fountzila A; Zaraboukas T; Kostopoulos I; Perifanis V; Fotiadis S; Hadjimiltiades S
    Hellenic J Cardiol; 2018; 59(3):182-185. PubMed ID: 29247778
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
    Provencio M; Fayad LE
    Med Clin (Barc); 2008 Jan; 130(2):60-5. PubMed ID: 18221676
    [No Abstract]   [Full Text] [Related]  

  • 39. Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae.
    Marks R; Engelhardt M; Hager S; Füllgraf H; Südkamp NP; Herget GW
    Ann Hematol; 2018 Aug; 97(8):1497-1500. PubMed ID: 29574568
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
    Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
    Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.